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Abstract Mice homozygous for the targeted disruption
of the growth hormone (GH) receptor (Ghr) gene (GH
receptor knockout; GHRKO; KO) are hypoinsulinemic,
highly insulin sensitive, normoglycemic, and long-
lived. Visceral fat removal (VFR) is a surgical interven-
tion which improves insulin signaling in normal (N)
mice and rats and extends longevity in rats. We have
previously demonstrated decreased expression level of
certain pro-apoptotic genes in skeletal muscles and
suggested that this may contribute to the regulation of
longevity in GHRKO mice. Alterations in apoptosis-
related genes expression in the kidneys also may
potentially lead to lifespan extension. In this context,
we decided to examine the renal expression of the
following genes: caspase-3, caspase-9, caspase-8, bax,
bad, bcl-2, Smac/DIABLO, Apaf-1, p53, and cyto-
chrome c1 (cyc1) in male GHRKO and N mice
subjected to VFR or sham surgery, at approximately
6 months of age. The kidneys were collected 2 months
after VFR. As a result, caspase-3, caspase-9, and bax
expressions were decreased in KO mice as compared to
N animals. Expressions of Smac/DIABLO, caspase-8,
bcl-2, bad, and p53 did not differ between KOs and N
mice. VFR did not change the expression of the
examined genes in KO or N mice. In conclusion,
endocrine abnormalities in GHRKO mice result in
decreased expression of pro-apoptotic genes and VFR
did not alter the examined genes expression in N and
KO mice. These data are consistent with a model in
which alterations of GH signaling and/or insulin
sensitivity lead to increased lifespan mediated by
decreased renal expression of pro-apoptotic genes.
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Introduction
Growth hormone (GH) receptor/GH binding protein
knockout mice (GHRKO; KO) are GH resistant due
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93-338 Lodz, Polandto targeted disruption of the GH receptor/GH binding
protein (Ghr/bp) gene (Zhou et al. 1997). These mice
are insulin sensitive and live longer than their normal
(N) siblings, and are characterized by reduced weight
and body size, not detectable concentration of GH
receptor, high level of serum GH, greatly reduced
plasma levels of IGF-I and insulin, and low or normal
glucose (Bartke and Brown-Borg 2004; Bartke et al.
2002; Coschigano 2006; Coschigano et al. 2000;
2003; Harper et al. 2006; Kopchick and Laron 1999;
Liu et al. 2004; Zhou et al. 1997). Moreover, GHRKO
mice have improved oxidative stress resistance and
reduced oxidative damage (Bartke and Brown-Borg
2004; Salmon et al. 2005; Sun et al. 2009) with lower
incidence and delayed onset of fatal neoplastic
diseases (Ikeno et al. 2009).
Visceral fat removal (VFR) is a surgical interven-
tion which has been reported to improve insulin
signaling in N mice and rats and extend longevity in
rats (Barzilai et al. 1999; Muzumdar et al. 2008; Shi
et al. 2007), thus mimicking the effects of calorie
restriction (CR). It is known that adipose tissue,
through the production of pro-inflammatory cytokines
(tumor necrosis factor-α, interleukin-6, interleukin-
1β) may cause the alterations in insulin sensitivity
leading to the insulin resistance (Fasshauer and
Paschke 2003; Lagathu et al. 2003; Zhang et al.
2001). Moreover, some of these cytokines could
induce apoptosis (Murata et al. 2010;S i s h ia n d
Engelbrecht 2011). In contrast, Holland et al. (2011)
have recently demonstrated that adiponectin, an
adipose tissue hormone which is known to improve
insulin sensitivity, exert anti-inflammatory effects,
and promote cell survival, may exert anti-apoptotic
effects as well. These effects are caused by stimula-
tion of ceramidase activity, and as a result of that,
enhanced ceramide catabolism and formation of its
anti-apoptotic metabolite—sphingosine-1-phosphate
(Holland et al. 2011). Interestingly, the long-living
GHRKO mice have been shown to have increased
plasma levels of adiponectin (Berryman et al. 2004).
Thus, it is not clear what over-riding effect VFR
might have in the GHRKO mice.
Apoptosis is involved in the regulation of age-related
functional alterations and longevity. Two central
apoptotic signaling pathways are known: intrinsic
(mitochondrial) (involving p53, bax, cytochrome c,
and caspase-9, among others)—initiated by different
factors within the cell (Boatright and Salvesen 2003;
Budihardjo et al. 1999; Jin and El-Deiry 2005), and
extrinsic (death receptor) pathway (involving caspase-
8) (Boatright and Salvesen 2003). In spite of its well-
known benefits, leading to removal of abnormal cells,
the role of apoptosis in longevity regulation is still
unclear. Deletion of GH receptor decreased the
expression level of some (caspase-3, caspase-9, bax,
and Smac/DIABLO) but not all apoptosis-related genes
in skeletal muscles, and we hypothesized that these
alterations may play a role in the regulation of
longevity in these knockout mice (Gesing et al.
2011). Interestingly, the double mutants produced by
crossing mice with caspase-3 gene deletion (casp3−/−)
and mice harboring the congenital polycystic kidney
(cpk) mutation lived longer than control cpk animals
(Tao et al. 2008). As apoptosis appears to increase in
the normal aging kidney (Miyazawa et al. 2009)a n d
pathological changes in kidneys are a very common
cause of death in aging mice (Barton et al. 2000;D o ie t
al. 1988; Zheng et al. 2004), we decided to continue
the study of apoptotic processes in the kidney of long-
lived GHRKO mice. In the present study, we have
examined the renal expression levels of the following
apoptosis-related genes: caspase-3, caspase-9, caspase-
8, bax, bad, bcl-2, Smac/DIABLO, Apaf-1, p53, and
cytochrome c1 (cyc1) in KO and N mice after VFR or
sham surgery.
Materials and methods
Animals, visceral fat removal, and assessment
of blood chemistry
The normal and GHRKO mice used in the present
study were produced in our breeding colony, devel-
oped using animals kindly provided by Dr. J.J.
Kopchick (Ohio University). Animals were produced
by mating knockout (−/−) males with heterozygous
(+/−) females. Normal (+/−) and GHRKO animals
(−/−) were separated by phenotypic characteristics.
All animal procedures were approved by the Labora-
tory Animal Care and Use Committee at the Southern
Illinois University School of Medicine (Springfield,
IL). The mice were housed under temperature- and
light-controlled conditions (22±2°C, 12 h light/12 h
dark cycle) and fed Lab Diet 5001 chow (PMI
Nutrition International, Richmond, IN) containing
4.5% fat and 23.4% protein. At the age of approxi-
296 AGE (2012) 34:295–304mately 6 months, 43 normal and GHRKO male mice
were grouped according to average body weight
within the phenotype, and divided into four experi-
mental groups: normal sham-operated (N-sham; 11
animals), normal subjected to visceral fat removal (N-
VFR; 11 animals), GHRKO sham-operated (KO-
sham; 10 animals), and GHRKO subjected to visceral
fat removal (KO-VFR; 11 animals). The animals were
anesthetized with ketamine/xylazine, shaved, and
prepared in the usual sterile fashion. Mice were
supplied with ibuprofen in drinking water starting
2 days before and up to 3 days after the surgery. Tap
water was available at all times to all animals. In the
VFR group, the epididymal fat pads were removed
using blunt dissection through a vertical midline
incision. Perinephric fat pads were removed via flank
incisions. We removed as much epididymal or
perinephric fat as was possible without compromising
blood supply to the testes and to the adrenals. For
sham operations, the abdominal cavity and both sides
of the back were incised, and the visceral fat was
mobilized but not removed. Two months after VFR or
sham operations, the animals were fasted overnight,
and fasting glucose levels were measured in blood
collected from the tail vein using OneTouch Ultra
glucometer (Life Scan, Milpitas, CA). Next, the mice
were anesthetized using ketamine/xylazine, bled by
cardiac puncture, and euthanized by decapitation.
Kidneys were rapidly collected, quickly frozen on
dry ice, and stored at −80°C until processed. Plasma
obtained from blood collected by cardiac puncture
was used for assessment of insulin using Rat/Mouse
Insulin ELISA (Linco Research Inc., St. Charles,
MO) following manufacturer’s protocols.
RNA extraction and complementary DNA
transcription
The RNA was extracted from the homogenates of
kidneys using guanidinium thiocyanate-phenol-
chloroform method based on Chomczynski–Sacchi
procedure (1987). RNA quantity and quality were
analyzed on 1.5% agarose gel using electrophoresis.
Potentially contaminating residual genomic DNA was
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Fig. 1 Caspase-3 (A), caspase-9 (B), and bax (C) mRNA
expression in the kidney of normal (N) and growth hormone
receptor/binding protein knockout (GHRKO; KO) mice sham-
operated (sham) or subjected to visceral fat removal (VFR). The
data from RT-PCR were normalized by the housekeeping gene
β2-microglobulin and expressed as the relative expression.
Values are means±SEM. a—values that share the same letter in
the superscript are not significantly different. *p=0.027 vs. N
mice (the significance for genotype), **p=0.043 vs. N mice
(the significance for genotype), ***p=0.042 vs. N mice (the
significance for genotype)
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ison, WI). Reverse transcription was performed and
complementary DNA was synthesized using an iScript
cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules,
CA) in accordance with manufacturer’s instruction.
Real-time polymerase chain reaction
The real-time polymerase chain reaction (RT-PCR)
was carried out using the Smart Cycler instrument
(Cepheid, Sunnyvale, CA) with iQ SYBR Green
Supermix (Bio-Rad Laboratories, Hercules, CA). The
three steps of the PCR included: denaturation at 94°C
for 2 min, annealing at 62°C for 30 s with
fluorescence reading, and extension at 72°C for
30 s. In addition, a melting curve was done for each
reaction to evaluate the potential of nonspecific
products. β2-Microglobulin (B2M) was used as a
housekeeping gene; it has been previously validated
in our laboratory as the most appropriate gene for
normalizing the data (Masternak et al. 2006). The
gene expression was assessed by measurement of
steady state levels of mRNA. Relative expression
from RT-PCR was calculated from the equation 2
A−B/
2
C−D (where A=cycle threshold [Ct] number for the
gene of interest in the first control sample, B=Ct
number for the gene of interest in the analyzed
sample, C=Ct number for the housekeeping gene in
the first control sample, and D=Ct number for
housekeeping gene in the analyzed sample). The first
control was expressed as 1.00 by this equation, and all
other samples were calculated in relation to this value.
Then, the results in the control group (N-sham) were
averaged, and all other outputs were divided by the
mean value of the relative expression in the control
group to yield the fold change of the expression of
genes of interest compared to the control group.
For RT-PCR the following primers were used
[gene bank sequence number by each forward
primer]:
B2M: forward [NM_009735]: 5′-aagtatactcacgc
caccca, backward: 5′-aagaccagtccttgctgaag;
caspase-3: forward [NM_009810]: 5′-tgcagcatgct
gaagctgta, backward: 5′-gagcatggacacaatacacg;
caspase-9: forward [NM_015733]: 5′-agcagagag
tagtgaagctg, backward: 5′-acacagacatcatgagctcc;
caspase-8: forward [AJ007749]: 5′-accgagatcctgt
gaatgga, backward: 5′-tgctttcccttgttcctcct;
bax: forward [NM_007527]: 5′-ccaccagctctgaa
cagatc, backward: 5′-cagcttcttggtggacgcat;
bad: forward [NM_007522]: 5′-agagtatgttcca
gatcccag, backward: 5′-gtcctcgaaaagggctaagc;
bcl-2: forward [NM_009741]: 5′-tgggatgcctttgtg
gaact, backward: 5′-gagacagccaggagaaatca;
Smac/DIABLO: forward : [NM_023232] 5′-
aagagctgcaccagaaagca, backward: 5′-tctgactgt
caatggcagga;
Table 1 Relative gene expression (as percent deviation from control group—N-sham) in kidneys of normal (N) and growth hormone
receptor/binding protein knockout (KO) mice sham-operated (sham) or subjected to visceral fat removal (VFR)
Gene N-sham
(A)
N-VFR
(B)
KO-sham
(C)
KO-VFR
(D)
p value,
A vs. B
p value,
C vs. D
p value,
A vs. C
p value,
B vs. D
p value, AB
vs. CD (N
vs. KO)
p value, AC
vs. BD (sham
vs. VFR)
Caspase-3 100±29% 169±57% 70±12% 44±5% NS NS NS NS 0.027 NS
Caspase-9 100±33% 131±28% 78±17% 52±5% NS NS NS NS 0.043 NS
bax 100±49% 40±8% 19±2% 17±1% NS NS NS NS 0.042 NS
Apaf-1 100±12% 83±11% 203±51% 197±17% NS NS NS 0.034 <0.001 NS
cyc1 100±10% 92±10% 207±39% 192±19% NS NS 0.008 0.012 <0.001 NS
Smac/DIABLO 100±28% 94±13% 84±14% 67±5% NS NS NS NS NS NS
caspase-8 100±10% 92±8% 120±14% 108±9% NS NS NS NS NS NS
bcl-2 100±44% 77±16% 83±24% 59±10% NS NS NS NS NS NS
bad 100±28% 99±16% 89±16% 59±5% NS NS NS NS NS NS
p53 100±26% 115±19% 123±28% 107±12% NS NS NS NS NS NS
Values are means±SEM
NS no significant
298 AGE (2012) 34:295–304Apaf-1: forward [AF064071]: 5′-tacaacgctctgcta
cacga, backward: 5′-cacacagcactgtccttaca;
p53: forward [AF151353]: 5′-tcacagtcggatat
cagcct, backward: 5′-acactcggagggcttcactt;
cytochrome c1: forward [NM_025567]: 5′-tacaag
caggtgtgctcttc, backward: 5′-atcattagggccatcctgga.
Statistical analysis
The data are expressed as mean±standard error of
the mean (SEM). To evaluate the effects of the
genotype and surgical intervention, two-way analy-
sis of variance, was used. A t test was used to
evaluate the effects of surgery within genotypes and
genotypes within surgical interventions. A value of
p<0.05 was considered significant. All statistical
calculations were conducted using SPSS version
17.0 (SPSS, Chicago, IL) with α=0.05. All graphs
were made using Prism 4.02 (GraphPad Software,
San Diego, CA).
Results
Expression of caspase-3 gene was decreased in kidneys
of KO as compared to normal (N) mice (p=0.027)
(Fig. 1A, Table 1). Similarly, the caspase-9 (Fig. 1B,
Table 1)a n db a x( F i g .1C, Table 1)m R N Al e v e l sw e r e
decreasedinKOsincomparisontoNanimals(p=0.043,
p=0.042, respectively). In contrast, the mRNA levels
of Apaf-1 (Fig. 2A,T a b l e1) and cyc1 (Fig. 2B,
Table 1) were increased in knockouts as compared to N
mice (p<0.001 both). Moreover, the level of Apaf-1
mRNA was up-regulated in KOs subjected to VFR
(KO-VFR) in comparison to N mice after VFR (p=
0.034) (Fig. 2A, Table 1). Additionally, there was
increased cyc1 expression in KO-sham and KO-VFR
mice, in comparison to the corresponding N mice
(p=0.008, p=0.012, respectively) (Fig. 2B, Table 1).
Expression of Smac/DIABLO (Fig. 3A, Table 1),
caspase-8 (Fig. 3B, Table 1), bcl-2 (Fig. 3C, Table 1),
bad (Fig. 3D,T a b l e1), and p53 (Fig. 3E, Table 1)i n
KO mice did not differ from values measured in N
animals. VFR did not change the expression of the
examined genes in the kidneys of KO or N mice
(Figs. 1, 2,a n d3, Table 1).
Glucose levels were increased in GHRKO mice
after VFR in comparison to sham-operated knockouts
(p=0.009), while in normal mice, there was a trend in
the opposite direction, i.e., reduction of glucose after
VFR (Fig. 4A). Moreover, there was a significant
genotype/VFR interaction for glucose levels (p=
0.016) (Fig. 4A). Interestingly, fasting insulin levels
were significantly decreased after VFR in normal
mice (p=0.019) (Fig. 4B).
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Fig. 2 Apaf-1 (A) and cyc1 (B) mRNA expression in the
kidney of normal (N) and growth hormone receptor/binding
protein knockout (KO) mice sham-operated (sham) or subjected
to visceral fat removal (VFR). The data from RT-PCR were
normalized by the housekeeping gene β2-microglobulin and
expressed as the relative expression. Values are means±SEM.
a, b—values that do not share the same letter in the superscript
are significantly different (p<0.05). *p<0.001 vs. N mice (the
significance for genotype), **p<0.001 vs. N mice (the
significance for genotype)
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The kidneys are organs which are strongly affected by
aging (Percy et al. 2008; Yang and Fogo 2010) that
may cause increased glomerulosclerosis, interstitial
fibrosis, tubular atrophy, and a loss of functional renal
tissue, involving the number of nephrons and also
glomeruli and tubules in the cortex. These histologic
features may lead, among others, to increased renal
vascular resistance and reduced renal plasma flow.
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Fig. 3 Smac/DIABLO (A), caspase-8 (B), bcl-2 (C), bad (D),
and p53 (E) mRNA expression in the kidney of normal (N) and
growth hormone receptor/binding protein knockout (KO) mice
sham-operated (sham) or subjected to visceral fat removal
(VFR). The data from RT-PCR were normalized by the
housekeeping gene β2-microglobulin and expressed as the
relative expression. Values are means±SEM. a—values that
share the same letter in the superscript are not significantly
different
300 AGE (2012) 34:295–304The process of apoptosis that is involved in the
regulation of development and health maintenance,
has not been, as yet, completely examined in long-
lived GHRKO mice. It is known that the level of
apoptosis increases during aging. Miyazawa et al.
(2009) showed that protein level of cytochrome c, the
leakage of which from mitochondria to the cytoplasm
is considered as one of markers of apoptosis,
increased 3.5-fold in kidney of 24-month-old com-
pared to 2-month-old C57BL/6J mice. Thus, the
suppression of apoptosis would seem to be beneficial
physiological effect in the context of prolonged
lifespan.
As was mentioned above, we observed decreased
expression of certain pro-apoptotic genes (caspase-3,
caspase-9, bax, and Smac/DIABLO) in skeletal
muscles of KOs that may contribute to the regulation
of longevity in these knockouts (Gesing et al. 2011).
For all the abovementioned reasons, it was of interest
to assess the expression of apoptosis-related genes in
kidneys of GHRKO mice.
In the present study, the expression level of main
effector (executioner) caspase—caspase-3—was de-
creased in kidneys of GHRKO mice as compared to
normal animals. This change may be considered as
potentially beneficial for longevity extension in KOs
because a change in the opposite direction, an
increase in caspase-3 expression was reported in
various pathological conditions. The increased ex-
pression of caspase-3 has been reported in ischemic
injury to kidney (Faubel and Edelstein 2005; Zhang et
al. 2006). Moreover, the renal level of caspase-3
expression was markedly increased in polycystic
kidney disease mice (Ali et al. 2000). The decreased
caspase-3 expression in insulin-sensitive GHRKO
mice may correspond to the observation that type 2
diabetic db/db mice with a point mutation in the leptin
receptor gene, leading to insulin resistance, among
others (Moien-Afshari et al. 2008), have increased
renal caspase-3 activity (Ghosh et al. 2009). Interest-
ingly, the caspase inhibitor IDN-8050 slowed the
disease progression in the Han:SPRD rat model of
polycystic kidney disease (Tao et al. 2005).
In our present study, the mRNA level of caspase-9
was decreased in GHRKO mice. This change in
caspase-9 expression also may be regarded as
beneficial for these insulin-sensitive mice and consis-
tent with the results of the study performed by Mishra
et al. (2005) in which the authors demonstrated that
high glucose increased caspase-9 activity in human
mesangial cells.
The targeted disruption of the Ghr gene leads to
decreased bax expression. It could be speculated
that this change may be beneficial for GHRKO
mice. It has been shown that β-catenin/Wnt
signaling pathway may promote survival of epithe-
lial cells in kidney after metabolic stress and this
beneficial effect seems to be associated with
inhibiting bax expression (Wang et al. 2009). In
agreement with our results, the opposite—increased
bax expression—was observed in renal cortex of
diabetic db/db mice (Ortiz et al. 1997)a n da l s oi n
cystic kidneys of congenital polycystic kidney
d i s e a s em i c e( A l ie ta l .2000).
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Fig. 4 Blood glucose (A) and plasma insulin (B) level in
normal (N) and growth hormone receptor/binding protein
knockout (KO) mice sham-operated (sham) or subjected to
visceral fat removal (VFR). Values are means±SEM. a, b—
values that do not share the same letter in the superscript are
significantly different (p<0.05)
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Apaf-1 expression in KO mice. This change seems to
be difficult to explain in the context of results
obtained in the present study for other apoptosis-
related genes. Nevertheless, it could be hypothesized
that this up-regulation of Apaf-1 expression may have
some beneficial implication in KO mice. It is known
that Apaf-1 null mice have many developmental
defects, and embryos lacking Apaf-1 show severe
craniofacial deformation and retention of interdigital
webs (Hickman and Helin 2002).
The cyc1 gene expression also was up-regulated in
the kidneys of GHRKOs. However, it was previously
reported that cytochrome c release may occur without
loss of membrane potential, which normally precip-
itates opening of the permeability transition pores
(Gross et al. 1999). Furthermore, cytochrome c is also
involved in the electron transport chain. Thus,
interpretation of the findings concerning cytochrome
c gene expression is complicated by its multiple roles
in physiological processes.
As mentioned previously, VFR may improve insulin
signaling inNmiceand ratsand extendlongevity inrats
(Barzilai et al. 1999;M u z u m d a re ta l .2008; Shi et al.
2007). These alterations resemble the effects of calorie
restriction (CR). In our present study, VFR did not
alter the expression of the examined apoptosis-related
genes in GHRKO and normal mice. These results seem
to be consistent with our previous observation that CR
did not affect apoptosis-related genes expression in
GHRKO mice (Gesing et al. 2011).
After VFR, glucose levels were increased in
GHRKO mice in comparison to sham-operated knock-
outs. Furthermore, VFR caused a decrease of fasting
insulin levels in normal mice. These preliminary results
show that VFR may promote insulin resistance in
GHRKO mice, although it had the expected beneficial
effect on insulin signaling in normal mice. Therefore,
one could speculate that the role of visceral fat in the
regulation of insulin signaling in the N mice and mice
with deletion of growth hormone receptor may be
different and needs further analysis.
In summary, endocrine abnormalities in GHRKO
mice result in decreased expression of pro-apoptotic
genes and VFR did not alter the examined genes
expression in N and KO mice. These data are
consistent with a model in which alterations of GH
signaling and/or insulin sensitivity lead to increased
lifespan mediated by decreased renal expression of
pro-apoptotic genes. Nevertheless, further studies are
still needed to determine how the expression levels of
apoptosis-related genes in particular organs can
contribute to the regulation of longevity.
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